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Shoulder hemiarthroplasty is a viable option in young patients with an intact rotator cuff in order to preserve the native glenoid. To
avoid the dreaded and expected wear of the glenoid in very active shoulders, implants with humeral head coated with a high
resistant and elastic material—pyrolytic carbon—are now an option. The authors present the first pyrocarbon coated
hemishoulder arthroplasty performed at our Orthopedic Department in a patient with osteonecrosis of the humeral head. At
three years of follow-up, the patient is pain free and without limitations in his daily work. The Constant score was applied pre-
and postoperatively, and an improvement of 32 points was reported. Larger cohorts with long-term follow-up are required to
confirm our promising results.
1. Introduction
Osteonecrosis of the humeral head (OHH), also known as
avascular necrosis or aseptic necrosis, is an uncommon dis-
ease that results from a temporary or permanent interruption
of blood supply to the humeral head [1] . The humeral head
is the second most common site of nontraumatic osteonecro-
sis but the overall prevalence is still unknown [2, 3]. What we
know has been extrapolated from research on osteonecrosis
of the hip. When the humeral head collapses and the shoul-
der function is diminished, arthroplasty is the most reliable
option [4]. Since most of the patients are younger than those
with osteoarthritis (OA), it is important to choose a durable
implant that can withstand the high functional demands [5,
6]. However, there is still a lack of consensus on the best ther-
apeutic option. If on the one hand, total shoulder arthro-
plasty (TSA) can have a rate of glenoid loosening up to
50% at 10 years [7]; on the other hand, there is the expected
glenoid cartilage erosion and subsequent revision after a
shoulder hemiarthroplasty (HSA) [8]. A pyrocarbon (PyC)
coated humeral head in HSA was hypothesized to overcome
the limitations of HSA as it is a durable implant that gener-
ates little or no cartilage wear [6, 9, 10].
The authors present the clinical and radiologic prelimi-
nary outcomes of the first PyC coated HSA performed in
our Orthopedic Department at 3 years of follow-up.
2. Clinical Case
A 48-year-old male, construction worker, with a medical his-
tory of high blood pressure, chronic obstructive pulmonary
disease, diabetes mellitus, and osteonecrosis of the right
femoral head was referred for shoulder consultation due to
progressive left shoulder pain associated with stiffness and
loss of function. On physical examination, he presented 120°
of forward elevation, 10° of external rotation and internal
rotation to L5, pain on passive and active mobilization, and
46 points in the Constant score. Plain radiographs and
magnetic resonance imaging (MRI) of the left shoulder
showed a collapse of the humeral head (stage III according
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to Cruess classification [11]) with a large osteophyte in the
lower region and the characteristic crescent sign
(Figure 1)—imaging findings consistent with OHH. Rotator
cuff rupture was not objectified.
Based on age, level of activity (hard manual labour), and
integrity of the rotator cuff, the patient underwent an HSA
with a PyC head (Aequalis Ascend™ Flex, Tornier). The sur-
gery was performed using a deltopectoral approach in the
beach chair position. The subscapular tendon was detached
using the “peeling” technique. The anatomical resection of
the head was performed with the help of a cutting guide. A
PyC head 48mm × 18mm (off-set 1.5mm) with a 5C nonce-
mented humeral short stem that was implanted. Intraopera-
tively, no acute or chronic lesions were detected in the
glenoid cartilage. At the end of the procedure, a full range
of motion was confirmed.
The patient followed the standard rehabilitation protocol
of our service with 4 weeks of immobilization and 6 months
of physiotherapy. Patient was observed for follow-up after 15
days, 6 weeks, 3 months, 1 year, and then at yearly intervals.
Currently, at 3 years of follow-up, the patient remains
painless, without limitations in his daily work, with 160° of
forward elevation, 30° of external rotation, and internal rota-
tion to T8 (Figure 2). The patient scored 78 points in the
Constant score—an improvement of 32 points compared to
the preoperative score. The radiological assessment revealed
no implant failure and no glenoid erosion (Figure 3).
3. Discussion
Despite the imaging changes, it takes time until patients start
complaining. Unlike hip joint, glenohumeral joint is neither a
load joint or a constrained joint. Therefore, it can tolerate big
deformities [12].
Nevertheless, when severe humeral head collapse occurs,
shoulder arthroplasty, either partial or total, is an option that
should be considered. Preoperatively assessment is the key to
a correct diagnosis. In radiograph plains, the lesion is com-
monly located in the superior middle portion of the humeral
head (best visualized on an anteroposterior view).With a sen-
sitivity of almost 100%, MRI is the preferred imaging method
in detecting early lesions (precollapse stages) [4]. The pres-
ence of the crescent sign represents the collapse of the
subchondral bone and separation from the cartilage [4, 13].
In fact, osteonecrosis accounts for approximately 5% of
all shoulder arthroplasties performed [14]. The main prob-
lem is dealing with an entity that affects younger shoulders
than those with OA. The clear lack of consensus regarding
the best implant in young patients is because of the limited
longevity of implants in shoulders with high functional
demands [7]. In 2004, Parson et al. [15] described a narrow-
ing of 68% of the glenohumeral joint space during the follow-
up interval of 43 months of HSA. Herschel et al. [8] found
severe glenoid erosion in one-third of the HSA after a mean
postoperative time of 2.5 years. Despite high rates of symp-
tomatic glenoid erosion due to friction with a metallic surface
(up to 21% after 5 years follow-up 7) and the drop of satisfac-
tion rates over the time (satisfaction of only 25% after an
average of 17 years 5), HSA has been accepted by most
authors in young patients [6]. The good results may partially
be due to a simple procedure when compared to TSA and the
less difficulty achieving range of motion postoperatively [16].
Additionally, a glenoid without subchondral changes or
cysts, covered by an intact rotator cuff, has favorable condi-
tions to resist to erosion, as supported by Herschel et al.
[8], and the attempt to preserve bone can be helpful in later
revisions. Rispoli et al. [17] revised ten of fifty-one HSA (per-
formed for the treatment of glenohumeral OA), which was
done to treat painful glenoid arthrosis in nine of the ten. In
a systematic reviewof all TSA andHSA for the treatment of gle-
nohumeral OA with a minimal follow-up of 7 years, Bekerom
et al. [18] identified a higher revision rate for any reason in
the HSA group (13%) than the TSA group (7%). Therefore,
when the expected cartilage wear becomes painful, it is recom-
mended to perform the revision of the HSA [15–17].
In contrast, because of the unreliable outcomes of HSA
and the uncertain about the wear predisposing factors, some
authors prefer TSA as the primary treatment of OHH. Some
refer better outcomes in short and middle terms [6]. Sperling
et al. [19] concluded that TSA seems to be the preferred pro-
cedure for pain relief, improvement in abduction, and to low-
ering the risk of revision surgery, among those with an intact
rotator cuff. Nevertheless, the durability of the glenoid com-
ponent is limited and becomes symptomatic or fails at 1.2%
per year [5]. The glenoid loosening accounts for 24% of all
TSA complication [20]. This weak spot is also well demon-
strated in the study of Feeley et al. [21] that reported compli-
cation rates of 22% and 8% in TSA and HA, respectively, in
the treatment of OHH and in the study of Gonzalez et al.
[22], with the same complication rates following TSA.
To overcome the main trigger for revision in HSA—-
symptomatic glenoid—PyC coated HSA was developed [8,
9, 16]. This manmade biomaterial has the best combination
of blood compatibility and physical and mechanical proper-
ties [9]. PyC has demonstrated decreased bone wear com-
pared to metal in in vitro models [10], and it is believed to
promote neosynthesis of a cartilage-like tissue [7]. Despite
previous orthopedic applications in small arthritic joint such
as the hand and wrist, outcomes in the glenohumeral joint
are beginning to emerge. Yet, most of the studies report out-
comes in interposition arthroplasty—pyrocarbon coated
interposition shoulder arthroplasty (PISA)—and some even
compare to HSA and TSA [5–7, 9]. The lack of results of
PyC coated HSA is notorious. In 2018, Klawitter et al. [10]
supported the use of PyC in humeral head HSA instead of
the conventional metal HSA and demonstrated less damage
to the bone in simulated tests for PyC HSA when compared
to cobalt chromium implants in in vitro models. A recent
prospective multicenter study performed by Garret et el
[6]., that included 65 patients who underwent PyC HSA,
demonstrated improvement in pain and function in patients
with primary and secondary OA.
We report preliminary outcomes of the first PyC coated
HSA performed in our Orthopedic Department, with a
follow-up of 3 years, with very encouraging results. The
patient is able to perform all ranges of motion, and the radio-
graphic assessment demonstrates good implantation of the
humeral stem and no evidence of secondary OA of the
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glenoid. Our results—improvement in the Constant score and
unchanged glenoid after 3 years of follow-up—were similar to
those reported in the atraumatic OHH group assessed in one
of the largest prospective multicenter study enrolling PyC
HSA [6]. Therefore, satisfactory functional recovery in a
young and active patient without uneventful events turns this
treatment into an attractive option in patients with OHH. Yet,
further investigations with larger cohorts assessing the radio-
graphs and functional outcomes are necessary to confirm the
safety and performance of PyC HSA in a long-term follow-up.
(a) (b) (c)
Figure 1: Anteroposterior plain radiograph of the left shoulder with the crescent sign, collapsed humeral head, and osteophyte (a); T2 coronal
magnetic resonance image with a collapsed humeral head and large osteophyte (b); T1 magnetic resonance image with grade 1 rotator cuff
muscle fatty infiltration (c).
Figure 3: Plain radiographs of the left shoulder with good implantation of the humeral steam and no evidence of glenoid erosion.
Figure 2: Functional outcomes three years after shoulder pyrocarbon hemiarthroplasty.
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